Our Leadership

Board Members

Masashi Miyamoto, Ph.D. (Profile)
Representative Director, Chairman of the Board

Masashi Miyamoto, Ph.D. Profile

Apr. 1985 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2011 Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Mar. 2012 Executive Officer, Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd.
Jul. 2014 Executive Officer, Director, Strategic Product Portfolio Department and Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd.
Apr. 2015 Executive Officer, Director, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2017 Director of the Board, Managing Executive Officer, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd.
Apr. 2017 Director of the Board, Managing Executive Officer, Director, Corporate Strategy & Planning Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2018 Representative Director of the Board, President, Kyowa Hakko Kirin Co., Ltd.
Apr. 2024 Representative Director of the Board, President & Chief Executive Officer(CEO), Kyowa Kirin Co., Ltd.
Mar. 2025 Representative Director of the Board, Chairman & Chief Executive Officer(CEO), Kyowa Kirin Co., Ltd.
Mar. 2026 Representative Director, Chairman of the Board, Kyowa Kirin Co., Ltd. (to present)
Abdul Mullick, Ph.D. (Profile)
Representative Director, President & Chief Executive Officer (CEO)

Abdul Mullick, Ph.D. Profile

Jan. 1999 Global Marketing Director, Diabetes, Hoechst Marion Roussel Ltd. (presently Sanofi-Aventis Pharma AG)
Jan. 2005 Senior Global Brand Director, Diabetes, Novartis Pharma AG
Dec. 2007 EMEA Business Unit Head, Genzyme Corp.
Jan. 2009 Vice President Commercial Operations – Japan, Asia-Pac, Australia & China, Genzyme Corp.
Jan. 2011 Vice President, Head of Global Marketing, Rare Diseases, Genzyme Corp.
Jul. 2013 Vice President & General Manager, Endocrinology and Cardiology, Rare Diseases, Genzyme USA
Sep. 2014 Executive Vice President, Head of Global Marketing, Vifor Pharma Ltd
Mar. 2018 Executive Vice President, Rare Disease Head, Kyowa Kirin International plc
Apr. 2019 President, Kyowa Kirin International plc
Jan. 2023 Managing Executive Officer, Vice Chief International Business Officer, Kyowa Kirin Co., Ltd.
Mar. 2023 Managing Executive Officer, Chief International Business Officer, Kyowa Kirin Co., Ltd.
Apr. 2024 Managing Executive Officer, Chief International Business Officer (CIBO), Kyowa Kirin Co., Ltd.
Mar. 2025 Representative Director of the Board, President and Chief Operating Officer (COO)
Mar. 2026 Representative Director of the Board, President and Chief Executive Officer (CEO) (to present)
Takeyoshi Yamashita, Ph.D. (Profile)
Director of the Board, Executive Vice President & Chief Scientific Officer (CSciO)

Takeyoshi Yamashita, Ph.D. Profile

Apr. 1987 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2010 Director, Innovative Drug Discovery Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2012 Director, Research Planning Department, Research Division, Kyowa Hakko Kirin Co., Ltd.
Apr. 2015 Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd.
Mar. 2017 Executive Officer
Director, Regulatory Affairs Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2019 Executive Officer
Director, Corporate Strategy and Planning Department, Kyowa Hakko Kirin Co, Ltd.
Mar. 2021 Managing Executive Officer
Director, Corporate Strategy and Planning Department, Kyowa Kirin Co., Ltd.
Mar. 2022 Managing Executive Officer
Vice President, Head of Strategy Division, Kyowa Kirin Co., Ltd.
Mar. 2023 Director of the Board, Senior Managing Executive officer, Head of Strategy Division, Kyowa Kirin Co., Ltd.
Apr. 2023 Director of the Board, Senior Managing Executive officer, Kyowa Kirin Co., Ltd.
Apr. 2024 Director of the Board, Senior Managing Executive officer & Chief Medical Officer(CMO), Kyowa Kirin Co., Ltd.
Mar. 2025 Director of the Board, Executive Vice President & Chief Medical Officer(CMO), Kyowa Kirin Co., Ltd.
Mar. 2026 Director of the Board, Executive Vice President & Chief Scientific Officer (CSciO), Kyowa Kirin Co., Ltd. (to present)
Daisuke Fujiwara, Ph.D. (Profile)
Director of the Board

Daisuke Fujiwara, Ph.D. Profile

Apr. 1995 Joined Kirin Brewery Company, Limited（presently Kirin Holdings Company, Limited）
Feb. 2005 Visiting Researcher, RIKEN Research Center for Allergy and Immunology
Sep. 2005 Postdoctoral Fellow, David Geffen School of Medicine at UCLA（USA）
Nov. 2007 Senior Researcher, Central Laboratories for Key Technologies, Kirin Holdings Company, Limited
May. 2014 Part-time Lecturer, Graduate School of Agricultural and Life Sciences, The University of Tokyo（to present）
Mar. 2021 General Manager, Health Science Department, Kirin Holdings Company, Limited
Apr. 2023 Executive Officer and General Manager of Institute of Health Sciences, Kirin Holdings Company, Limited
Mar. 2025 Director of the Board, Kyowa Kirin Co., Ltd.（to present）
Senior Executive Officer, President of R&D Division, Kirin Holdings Company, Limited（to present）
Takashi Oyamada, MBA (Profile)
Director of the Board (Independent Director)

Takashi Oyamada, MBA Profile

Apr. 1979 Joined The Mitsubishi Bank, Limited (presently MUFG Bank, Ltd.)
Jan. 2006 Executive Officer, The Bank of Tokyo-Mitsubishi UFJ, Ltd. (presently MUFG Bank, Ltd.)
Jan. 2009 Managing Executive Officer, The Bank of Tokyo-Mitsubishi UFJ, Ltd.
Jun. 2009 Managing Director, The Bank of Tokyo Mitsubishi UFJ, Ltd.
Member of the Board of Directors, Mitsubishi UFJ Financial Group, Inc.
May. 2012 Managing Executive Officer, The Bank of Tokyo-Mitsubishi UFJ, Ltd.
May 2013 Senior Managing Executive Officer, The Bank of Tokyo-Mitsubishi UFJ, Ltd.
Jun. 2014 Representative Director, Deputy President, The Bank of Tokyo-Mitsubishi UFJ, Ltd.
Jun. 2015 Member of the Board of Directors, Representative Corporate Executive, Deputy President and COO, Mitsubishi UFJ Financial Group, Inc.
Apr. 2016 Member of the Board of Directors, President & CEO, The Bank of Tokyo-Mitsubishi UFJ, Ltd.
Member of the Board of Directors, Mitsubishi UFJ Financial Group, Inc.
Jun. 2017 Senior Advisor, The Bank of Tokyo-Mitsubishi UFJ, Ltd. (to present)
Jun. 2018 Director and Vice Chair, The Japan Institute of International Affairs (to present)
Dec. 2018 Outside Director, Mitsubishi Research Institute DCS Co., Ltd. (to present)
Jun. 2019 Outside Director, Mitsubishi Electric Corporation
Outside Director, Isetan Mitsukoshi Holdings Ltd.
Mar. 2021 Outside Director of the Board, Kyowa Kirin Co., Ltd. (to present)
Yoshihisa Suzuki, MBA (Profile)
Director of the Board (Independent Director)

Yoshihisa Suzuki, MBA Profile

Apr. 1979 Joined ITOCHU Corporation
Jun. 2003 Executive Officer, ITOCHU Corporation
Apr. 2006 Managing Executive Officer, ITOCHU Corporation
Executive Vice President and CAO, ITOCHU International Inc.
Apr. 2007 President and CEO, ITOCHU International Inc.
Jun. 2011 Executive Vice President, JAMCO Corporation
Jun. 2012 President and CEO, JAMCO Corporation
Jun. 2016 Senior Managing Executive Officer, Member of the Board, ITOCHU Corporation
Apr. 2018 President and Chief Operating Officer (COO), Member of the Board, ITOCHU Corporation
Apr. 2020 President and Chief Operating Officer (COO), Chief Digital Officer (CDO), and Chief Information Officer (CIO), Member of the Board, ITOCHU Corporation
Apr. 2021 Vice Chairman, Member of the Board, ITOCHU Corporation
Mar. 2022 Outside Director of the Board, Kyowa Kirin Co., Ltd. (to present)
Apr. 2022 Vice Chairman, ITOCHU Corporation
Jun. 2022 Outside Director, OMRON Corporation (to present)
Apr. 2023 Senior Vice Representative for External Affairs, ITOCHU Corporation
Apr. 2024 Advisory Member, ITOCHU Corporation (to present)
Jun. 2025 Outside Director of JFE Holdings, Inc. (to present)
Rumiko Nakata (Profile)
Director of the Board (Independent Director)

Rumiko Nakata Profile

Apr. 1979 Joined Esso Sekiyu K.K.
Apr. 1996 Joined Center for Socio-Economic Research K.K.
Apr. 2000 Joined Pfizer K.K. (Pfizer Japan)
Dec. 2011 Head of HR and Global Operations, Pfizer K.K.
Mar. 2012 Corporate Officer, Pfizer K.K.
Jan. 2014 Director of the Board, Corporate Officer, Pfizer K.K.
Mar. 2018 Executive Officer, Diversity & Inclusion, Mitsubishi Chemical Corporation.
Apr. 2019 Managing Executive Officer, Supervising-Human Resources Department, Mitsubishi Chemical Corporation.
Apr. 2020 Director of the Board, Managing Executive Officer, Supervising – Administration Dept., Public Relations Dept., Human Resources Dept., Mitsubishi Chemical Corporation.
Mar. 2023 Outside Director of the Board, Kyowa Kirin Co., Ltd. (to present)
Jun. 2024 Outside Director, Denka Company Limited(to present)
Yukiko Ito, Ph.D. (Profile)
Director of the Board (Independent Director)

Yukiko Ito, Ph.D. Profile

Apr. 2006 Assistant Professor, Faculty of Economics, Tokyo Keizai University
Apr. 2009 Associate Professor, Department of Economics, Faculty of Humanities and Social Sciences, Tokyo Gakugei University
Jul. 2015 Committee member, Committee for the Promotion of Integrated Economic and Fiscal Reforms, Cabinet Office
Apr. 2018 Professor, College of Policy Studies, Tsuda University
Jul. 2018 Subcommittee Member, Pharmaceuticals and Medical Devices System, Health Sciences Council, Ministry of Health, Labor and Welfare（to present）
Apr. 2024 Director, Japan Community Healthcare Organization（to present）
Jun. 2024 Director, Pfizer Health Research Foundation（to present）
Mar. 2025 Outside Director of the Board, Kyowa Kirin Co., Ltd.（to present）
Apr. 2025 Professor, Graduate School of Business and Commerce, Keio University（to present）
Kenji Shibata, Ph.D. (Profile)
Director of the Board, Audit and Supervisory Committee Member

Kenji Shibata, Ph.D. Profile

Apr. 1992 Joined Kyowa Hakko Kogyo Co, Ltd. (presently Kyowa Kirin Co, Ltd.)
Apr. 2004 Senior Research Scientist, Tokyo Res. Labs., Kyowa Hakko Kogyo Co., Ltd.
Jul. 2009 Manager, Research Planning Dept., Research Div., Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co, Ltd.)
Apr. 2012 Group Head, Discovery Res. Labs., Research Div., Kyowa Hakko Kirin Co., Ltd.
Apr. 2014 Group Head, R&D Planning Dept., R&D Div., Kyowa Hakko Kirin Co., Ltd.
Apr. 2016 Deputy Director, R&D Planning Dept., R&D Div., Kyowa Hakko Kirin Co., Ltd.
Apr. 2018 Director, R&D Planning Dept., R&D Div., Kyowa Hakko Kirin Co., Ltd.
Mar. 2021 Executive Officer
Director, Internal Audit Department, Kyowa Kirin Co., Ltd.
Mar. 2026 Director of the Board, Audit and Supervisory Committee Member, Kyowa Kirin Co., Ltd. (to present)
Yoko Wachi (Profile)
Director of the Board, Audit and Supervisory Committee Member (Independent Director)

Yoko Wachi Profile

Apr. 1989 Joined Kajitani Law Offices
Admitted in Japan（Dai-Ichi Tokyo Bar Association）
Apr. 2006 Mediator of Family Conciliations, Tokyo Family Court（to present）
Jun. 2015 Outside Audit & Supervisory Board Member of NICHIAS CORPORATION
Mar. 2016 Outside Audit & Supervisory Board Member of Otsuka Holdings Co., Ltd.
Jan. 2019 Partner, Kajitani Law Offices（to present）
Apr. 2019 Vice President of the Tokyo Association of Family Conciliations
Jun. 2019 Outside Director of NICHIAS CORPORATION（to present）
Jun. 2023 Outside Director of S.T. CORPORATION（to present）
Mar. 2025 Outside Audit & Supervisory Board Member, Kyowa Kirin Co., Ltd.
Mar. 2026 Outside Director of the Board, Audit and Supervisory Committee Member, Kyowa Kirin Co., Ltd. (to present)
Hiroshi Kanno, MBA (Profile)
Director of the Board, Audit and Supervisory Committee Member (Independent Director)

Hiroshi Kanno, MBA Profile

Apr. 1983 Joined Nikken Sekkei Ltd.
Aug. 1991 Joined Boston Consulting Group, Inc.（presently Boston Consulting Group, LLC）
Jan. 2000 Partner & Managing Director, Boston Consulting Group, Inc. （presently Boston Consulting Group, LLC）
Jul. 2008 Professor, Hitotsubashi University Graduate School of International Corporate Strategy
Jun. 2011 Outside Director, OMRON Healthcare Co., Ltd.
Apr. 2012 Dean, Hitotsubashi University Graduate School of International Corporate Strategy
Jun. 2015 Outside Auditor, STANLEY ELECTRIC Co., Ltd.
Sep. 2016 Professor, Waseda Business School（Graduate School of Business and Finance）（to present）
Dec. 2016 Director, Unicharm Kyoshin Foundation（to present）
Sep. 2017 Outside Director, ERI Holdings Co., Ltd.
Sep. 2018 Director, Waseda University Institute for Business and Finance（to present）
Apr. 2020 Visiting Professor, The Open University of Japan
Jul. 2022 Director, Laboro.AI Inc.（to present）
Feb. 2023 Visiting Professor, School of Business, Aalto University（Finland）
Mar. 2025 Outside Director of the Board, Kyowa Kirin Co., Ltd.
Mar. 2026 Ourside Director of the Board, Audit and Supervisory Committee Member, Kyowa Kirin Co., Ltd. (to present)
Kohei Kan (Profile)
Director of the Board, Audit and Supervisory Committee Member (Independent Director)

Kohei Kan Profile

Sep. 1986 Registered as Certificated Public Accountant
Apr. 1987 Joined Mita Audit Corporation (currently Deloitte Touche Tohmatsu LLC)
Jun. 1998 Partner, Deloitte Touche Tohmatsu LLC
Nov. 2013 Board Member, Deloitte Tohmatsu Group and Deloitte Touche Tohmatsu LLC
Nov. 2015 Chief Executive Officer, Deloitte Touche Tohmatsu LLC
Jun. 2018 Senior advisor, Deloitte Tohmatsu LLC
Sep. 2018 Audit & Assurance Leader, Deloitte Asia Pacific Limited
Jan. 2020 Senior Advisor, Deloitte Asia Pacific Limited
Oct. 2020 Chief, Kan Kohei Certified Public Accountant Office (present)
Nov. 2020 Board Member, International Federation of Accountants “IFAC” (present)
Jan. 2022 Senior Advisor, The Japanese Institute of Certified Public Accouuntants (present)
Jun. 2022 Outside Director, Olympus Corporation (present)
Mar. 2026 Outside Director of the Board, Audit and Supervisory Committee Member, Kyowa Kirin Co., Ltd. (to present)

C-suite Executive

Masashi Miyamoto, Ph.D. (Profile)
Representative Director, Chairman of the Board

Masashi Miyamoto, Ph.D. Profile

Apr. 1985 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2011 Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Mar. 2012 Executive Officer, Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd.
Jul. 2014 Executive Officer, Director, Strategic Product Portfolio Department and Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd.
Apr. 2015 Executive Officer, Director, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2017 Director of the Board, Managing Executive Officer, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd.
Apr. 2017 Director of the Board, Managing Executive Officer, Director, Corporate Strategy & Planning Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2018 Representative Director of the Board, President, Kyowa Hakko Kirin Co., Ltd.
Apr. 2024 Representative Director of the Board, President & Chief Executive Officer(CEO), Kyowa Kirin Co., Ltd.
Mar. 2025 Representative Director of the Board, Chairman & Chief Executive Officer(CEO), Kyowa Kirin Co., Ltd.
Mar. 2026 Representative Director, Chairman of the Board, Kyowa Kirin Co., Ltd. (to present)
Abdul Mullick, Ph.D. (Profile)
Representative Director, President & Chief Executive Officer (CEO)

Abdul Mullick, Ph.D. Profile

Jan. 1999 Global Marketing Director, Diabetes, Hoechst Marion Roussel Ltd. (presently Sanofi-Aventis Pharma AG)
Jan. 2005 Senior Global Brand Director, Diabetes, Novartis Pharma AG
Dec. 2007 EMEA Business Unit Head, Genzyme Corp.
Jan. 2009 Vice President Commercial Operations – Japan, Asia-Pac, Australia & China, Genzyme Corp.
Jan. 2011 Vice President, Head of Global Marketing, Rare Diseases, Genzyme Corp.
Jul. 2013 Vice President & General Manager, Endocrinology and Cardiology, Rare Diseases, Genzyme USA
Sep. 2014 Executive Vice President, Head of Global Marketing, Vifor Pharma Ltd
Mar. 2018 Executive Vice President, Rare Disease Head, Kyowa Kirin International plc
Apr. 2019 President, Kyowa Kirin International plc
Jan. 2023 Managing Executive Officer, Vice Chief International Business Officer, Kyowa Kirin Co., Ltd.
Mar. 2023 Managing Executive Officer, Chief International Business Officer, Kyowa Kirin Co., Ltd.
Apr. 2024 Managing Executive Officer, Chief International Business Officer (CIBO), Kyowa Kirin Co., Ltd.
Mar. 2025 Representative Director of the Board, President and Chief Operating Officer (COO)
Mar. 2026 Representative Director of the Board, President and Chief Executive Officer (CEO) (to present)
Takeyoshi Yamashita, Ph.D. (Profile)
Director of the Board, Executive Vice President & Chief Scientific Officer (CSciO)

Takeyoshi Yamashita, Ph.D. Profile

Apr. 1987 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2010 Director, Innovative Drug Discovery Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2012 Director, Research Planning Department, Research Division, Kyowa Hakko Kirin Co., Ltd.
Apr. 2015 Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd.
Mar. 2017 Executive Officer
Director, Regulatory Affairs Department, Kyowa Hakko Kirin Co., Ltd.
Mar. 2019 Executive Officer
Director, Corporate Strategy and Planning Department, Kyowa Hakko Kirin Co, Ltd.
Mar. 2021 Managing Executive Officer
Director, Corporate Strategy and Planning Department, Kyowa Kirin Co., Ltd.
Mar. 2022 Managing Executive Officer
Vice President, Head of Strategy Division, Kyowa Kirin Co., Ltd.
Mar. 2023 Director of the Board, Senior Managing Executive officer, Head of Strategy Division, Kyowa Kirin Co., Ltd.
Apr. 2023 Director of the Board, Senior Managing Executive officer, Kyowa Kirin Co., Ltd.
Apr. 2024 Director of the Board, Senior Managing Executive officer & Chief Medical Officer(CMO), Kyowa Kirin Co., Ltd.
Mar. 2025 Director of the Board, Executive Vice President & Chief Medical Officer(CMO), Kyowa Kirin Co., Ltd.
Mar. 2026 Director of the Board, Executive Vice President & Chief Scientific Officer (CSciO), Kyowa Kirin Co., Ltd. (to present)
Yasuo Fujii, MBA (Profile)
Chief Business Officer (CBO) & Global Business Development Head

Yasuo Fujii, MBA Profile

Apr. 1988 Joined Kyowa Hakko Kogyo Co.,Ltd. (presently Kyowa Kirin Co., Ltd.)
Sep. 2011 Senior Vice President, ProStrakan, plc (presently Kyowa Kirin International, plc)
Sep. 2012 Executive Vice President, ProStrakan, plc
Jan. 2017 Deputy Director, Overseas Business Department, Kyowa Hakko Kirin (presently Kyowa Kirin Co.,Ltd.)
Mar. 2018 Executive Officer
Director, Business Development, Kyowa Hakko Kirin Co., Ltd.
Mar. 2023 Managing Executive Officer
Director, Business Development, Kyowa Kirin Co., Ltd.
Apr. 2023 Managing Executive Officer, Vice President, Head of Strategy Division, Kyowa Kirin Co., Ltd.
Apr. 2024 Managing Executive Officer and Chief Strategy Officer (CSO), Kyowa Kirin Co., Ltd.
Mar. 2026 Chief Business Officer (CBO), Kyowa Kirin Co., Ltd. (to present)
Shoko Itagaki (Profile)
Chief People Officer (CPO) & Global Human Resources Head

Shoko Itagaki Profile

Apr. 1995 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Mar. 2019 Director, Regulatory Affairs Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Mar. 2021 Executive Officer
Director, Corporate Strategy & Planning Department, Kyowa Kirin Co., Ltd.
Apr. 2022 Executive Officer
Director, Corporate Planning Department, Strategy Division, Kyowa Kirin Co., Ltd.
Apr. 2024 Executive Officer and Chief People Officer (CPO), Kyowa Kirin Co., Ltd.
Mar. 2025 Managing Executive Officer and Chief People Officer (CPO), Kyowa Kirin Co., Ltd.
Mar. 2026 Chief People Officer (CPO), Kyowa Kirin Co., Ltd. (to present)
Toshiyuki Kurata (Profile)
Chief Supply Chain Officer (CSCO) & Global Manufacturing Head

Toshiyuki Kurata Profile

Apr. 1995 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Apr. 2016 Director, Bio Process Research and Development Laboratories, Production Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2019 Director, Production Planning department, Production Division, Kyowa Hakko Kirin Co., Ltd.
Apr. 2021 Executive Officer
Vice Head of Production Division &
Director, Production Planning Department, Kyowa Kirin Co., Ltd.
Apr. 2022 Executive Officer
Vice President, Head of Production Division, Kyowa Kirin Co., Ltd.
Apr. 2024 Executive Officer, Chief Supply Chain Officer (CSCO) & Vice President, Head of Production Division, Kyowa Kirin Co., Ltd.
Apr. 2025 Managing Executive Officer and Chief Supply Chain Officer (CSCO), Kyowa Kirin Co., Ltd.
Mar. 2026 Chief Supply Chain Officer (CSCO), Kyowa Kirin Co., Ltd. (to present)
Yoshiko Mori (Profile)
Chief Compliance Officer (CCO)

Yoshiko Mori Profile

Apr. 1992 Joined Kyowa Hakko Kogyo Co., Ltd.(presently Kyowa Kirin Co., Ltd.)
Apr. 2009 Manager of Pharmacovigilance, Kyowa Hakko Kirin Co., Ltd.(presently Kyowa Kirin Co., Ltd.)
Oct. 2009 Manager of Human resources, Kyowa Hakko Kirin Co., Ltd.
Apr. 2014 Senior manager, Pharmacovigilance Division, Kyowa Hakko Kirin Co., Ltd.
Sep. 2019 Director of Pharmacovigilance, Kyowa Hakko Kirin Co., Ltd.
Jan. 2020 Vice Division Head of Pharmacovigilance, Kyowa Kirin Co., Ltd.
Dec. 2021 Vice President, Head of Pharmacovigilance Division, Kyowa Kirin Co., Ltd.
Mar. 2022 Executive Officer
Vice President, Head of Pharmacovigilance Division, Kyowa Kirin Co., Ltd.
Mar. 2024 Executive Officer
Director, CSR Management Department, Kyowa Kirin Co., Ltd.
Marketing Supervisor-General, Kyowa Kirin Co., Ltd.
Mar. 2025 Managing Executive Officer and Chief Compliance Officer (CCO), Kyowa Kirin Co., Ltd.
Mar. 2026 Chief Compliance Officer (CCO), Kyowa Kirin Co., Ltd. (to present)
Mitsuru Kameyama (Profile)
Chief Digital Transformation Officer (CDXO)

Mitsuru Kameyama Profile

Apr. 1980 Joined Nissan Motor Co., Ltd.,
Apr. 2005 Head of Information Systems Division, Dongfeng Motor Corporation (a joint venture in China)
Apr. 2012 General Manager of the Information Planning Department, Shiseido Company, Limited
Apr. 2013 President and CEO, Shiseido Information Network Co., Ltd.
Jan. 2016 Executive Officer and CITO (Chief Information Technology Officer), Shiseido Company, Limited
Feb. 2020 CDO (Chief Digital Officer), Mitsubishi Materials Corporation
Jan. 2023 Senior Executive Advisor, Globe-ing Inc.
Apr. 2025 Executive Officer
Chief Digital Transformation Officer (CDXO) and Head of ODX Department, Kyowa Kirin Co., Ltd.
Oct. 2025 Executive Officer, Chief Digital Transformation Officer (CDXO), Kyowa Kirin Co., Ltd.
Mar. 2026 Chief Digital Transformation Officer (CDXO), Kyowa Kirin Co., Ltd. (to present)
Yoshifumi Torii, Ph.D. (Profile)
Chief Medical Officer (CMO) & Global Development Head

Yoshifumi Torii, Ph.D. Profile

Apr. 1994 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited)
Oct. 2017 President & CEO, Fujifilm Kyowa Kirin Biologics Co., Ltd.
Oct. 2019 Deputy Director, Business Planning Department, Kyowa Kirin Co., Ltd.
Mar. 2020 Executive Officer
Vice President, Head of R&D Division,
Kyowa Kirin Co., Ltd.
Jan. 2024 Executive Officer
Vice President, Head of Research Division,
Kyowa Kirin Co., Ltd.
Mar. 2026 Chief Medical Officer (CMO), Kyowa Kirin Co., Ltd. (to present)
Koji Igarashi, MBA (Profile)
Chief Financial Officer (CFO)

Koji Igarashi, MBA Profile

Apr. 1997 Joined Ajinomoto Co., Inc.
Jun. 2001 Project Manager, Business Development, HBI Inc.
Aug. 2004 Finance Associate, Bristol-Myers Squibb
Mar. 2008 Associate Director, Strategic Analysis & Business Development, Technical Operations Finance, Bristol-Myers Squibb
Apr. 2010 Associate Director, Integration/M&A, R&D Finance, Bristol-Myers Squibb
Sep. 2014 Finance Director, US Immunoscience, Bristol-Myers Squibb
Oct. 2016 Director, International Treasury, Bristol-Myers Squibb
Jul. 2017 Global Head & Vice President, Corporate Planning & Analysis, Takeda Pharmaceutical Company Limited.
Jul. 2025 CFO & Senior Vice President, Japan Business Unit, Takeda Pharmaceutical Company Limited.
Mar. 2026 Chief Financial Officer (CFO), Kyowa Kirin Co., Ltd. (to present)
Tomohiro Sudo, M.S, MBA (Profile)
Japan and Asia Pacific (JAPAC) Region President

Tomohiro Sudo, M.S, MBA Profile

Apr. 1993 Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Ltd.)
Feb. 2001 Manager, Clinical Development, GEMINI SCIENCE, INC. (California, USA)
Apr. 2004 Vice President, GEMINI SCIENCE, INC. (California, USA)
Sep. 2009 Manager, Group No.2, Strategic Product Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.)
Apr. 2014 Deputy Director, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd
Apr. 2016 Global Product Lead for Crysvita, Kyowa Kirin International Plc (UK)
Jan. 2017 Executive Vice President of Kyowa Kirin International Plc (UK)
Apr. 2020 Executive Officer
Director, Strategic Product Planning Department, Kyowa Kirin Co., Ltd.
Apr. 2021 Executive Officer
Director, Global Product Strategy Department, Kyowa Kirin Co., Ltd. (to present)
Apr. 2022 Executive Officer
Director, Global Product Strategy Department, Strategy Division, Kyowa Kirin Co., Ltd.
Apr. 2024 Executive Officer
Director, Global Product Strategy Department, Kyowa Kirin Co., Ltd.
Mar. 2025 Managing Executive Officer and Chief International Business Officer (CIBO), Kyowa Kirin Co., Ltd.
Mar. 2026 Japan and Asia Pacific (JAPAC) Region President, Kyowa Kirin Co., Ltd. (to present)
Steve Schaefer, MBA (Profile)
North America (NA) Region President

Steve Schaefer, MBA Profile

May. 1991 Captain, United States Marine Corps
Jan. 1997 Primary Care and Neuroscience Sales Representative, Eli Lilly and Company, USA
Dec. 1998 Market Research Associate, New Antidepressant Team, Eli Lilly and Company, USA
Jan. 2001 Depression Commercialization Manager,
Neurosciences, Cymbalta, USA,
Eli Lilly and Company, USA
Oct. 2004
  • Pain Commercialization Manager
  • Brand Leader and Sr. Marketing Director
  • Senior Director, New Commercialization Model
  • Brand Leader and Senior Director, Cardiovascular Business
  • General Manager, Puerto Rico
  • Business Unit Leader, Specialty Health Organization
  • Next Generation Commercial Model Development

Eli Lilly and Company, USA
Jul. 2017
  • Senior Vice President, Business Unit Leader, General Medicines Business Unit
  • Senior Vice President, Business Unit Leader, Neuroscience Business Unit
  • Senior Vice President, Neuroscience BU Leader and Chief Operating Officer

Takeda Pharmaceuticals, USA
Apr. 2023 President, KKNA Director on Board of Directors, Kyowa Kirin USA Holdings, Inc. & Kyowa Kirin, Inc. (KKNA)
Mar. 2026 North America (NA) Region President, Kyowa Kirin USA Holdings, Inc. & Kyowa Kirin, Inc. (KKNA) (to present)
Julie Dehaene-Puype Pharm.D., MSc RA (Profile)
Europe, the Middle East, and Africa (EMEA) Region President

Julie Dehaene-Puype Pharm.D., MSc RA Profile

Jan. 1998 EU Regulatory Affairs Manager, Schering-Plough Europe
Nov. 2000
  • Global Marketing Business Research Analyst
  • Senior Product Manager (Oncology/Virology)
  • Pharmaceutical Sales Representative (Hepatitis)
  • Senior Product Manager, US Marketing (Virology)
  • Director, New Products
  • Director, Mid-Size EU Markets Operations

Schering-Plough Pharmaceuticals, US
Dec. 2009
  • Senior Director, Strategy Execution & Operations Europe/Canada
  • Associate VP, Commercial Operations Europe/Canada

Merck & Co., Inc., Europe/Canada
Sep. 2015
  • General Manager, Switzerland & VP, Customer Excellence Europe/Canada
  • Integration Lead, Europe/Canada
  • General Manager, France

Takeda Pharmaceutical Company Limited, Europe/Canada
Dec. 2020 Chief Commercial Officer, Europe/Canada, Mundipharma International Limited
Dec. 2023 Board Member, CYTEA BIO
Apr. 2025 Non-Executive Director, Lytix Biopharma (to present)
Nov. 2025 President, Kyowa Kirin International plc
Mar. 2026 Europe, the Middle East, and Africa (EMEA) Region President, Kyowa Kirin International plc (to present)
Bobby Gaspar, MD; PhD (Profile)
Orchard Therapeutics CEO

Bobby Gaspar, MD; PhD Profile

Sep. 1996 Lecturer and Registrar, UCL and Great Ormond Street Hospital, London
Apr. 2002 Senior Lecturer and Consultant, UCL and Great Ormond Street Hospital, London
Sep. 2007 Professor and Consultant, UCL and Great Ormond Street Hospital, London
Jan. 2018 Chief Scientific Officer, Orchard Therapeutics
Mar. 2020 Chief Executive Officer,Orchard Therapeutics
Mar. 2026 Managing Executive Officer of the Company and Chief Executive Officer, Orchard Therapeutics (to present)

Global Function Head

Yasuo Fujii, MBA
Chief Business Officer (CBO) & Global Business Development Head
Shoko Itagaki
Chief People Officer (CPO) & Global Human Resources Head
Toshiyuki Kurata
Chief Supply Chain Officer (CSCO) & Global Manufacturing Head
Yoshifumi Torii, Ph.D.
Chief Medical Officer (CMO) & Global Development Head
Takefumi Matsushita, Ph.D., MBA
Global Corporate Planning Head
Ikuko Okubo, MBA
Global Intellectual Property Head
Hideaki Matsumoto, MBA
Global Product Strategy Head
Nathan Hawes, MBA
Global Operational and Digital Transformation Head
Masaru Otsuka, MBA
Global Information and Communication Technology Head
Takaaki Uochi, Ph.D.
Global Compliance and Risk Management Head
Kazuki Nemoto
Global Legal Head
Ian Duguid PhD, MRPharmS
Global Regulatory Affairs Head
Jonathan Patroni, MBA
Global Quality Assurance Head
Eslie Dennis, MD, MBChB, FCP (SA)
Global Medical Affairs Head
Nilay Gami
Global Pharmacovigilance Head
Takashi Shimada
Global Research Head
Naohiko Kubo
Global Finance Head
Masahiro Hara, MBA
Global Procurement Head
Hiroki Nakamura
Global Corporate Communications Head
Jun Fukuda
Global Supply Chain Management Head
Toshiyuki Shimizu
Global Internal Audit Head